DI 400 x 400  copy jpeg.jpg
Robotic Angiography Systems Market Growth Is Driving By Rise In The Growth Of Heart And Kidney-Related Disorders | Report available on Douglas Insights
12 déc. 2022 02h49 HE | Douglas Insights
Isle of man, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Douglas Insights has added the Robotic Angiography System Market research to its growing market reports. Douglas insight is one of the best comparison...
ONOCOR logo.png
First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery
12 sept. 2022 08h40 HE | ONOCOR
PHILADELPHIA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary...
ONOCOR logo.png
ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Intracardiac Tumor
02 août 2022 08h09 HE | ONOCOR
PHILADELPHIA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC is excited to announce the first-in-human use of the ŌNŌ endovascular retrieval system for removal of an intracardiac tumor. Intracardiac...
AMR Logo.png
Vascular Graft Market Size is Expected to Reach $8.13 Billion by 2030: Allied Market Research
13 juin 2022 07h25 HE | Allied Market Research
Portland, OR, June 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Vascular Graft Market generated $4.99 billion in 2020, and is projected to...
ONOCOR logo.png
ŌNŌCOR Receives FDA Clearance for Novel Endovascular Retrieval Technology
25 mai 2022 08h00 HE | ONOCOR
PHILADELPHIA, May 25, 2022 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food and Drug Administration (FDA) clearance for...
XableCath Crossing Catheters FDA Cleared
30 janv. 2019 08h00 HE | XableCath, Inc.
New tool for crossing peripheral CTO’s and chronic venous obstructions SALT LAKE CITY, Jan. 30, 2019 (GLOBE NEWSWIRE) -- XableCath, Inc., announced that its XableCath™ blunt and abrasion tip...
energias.jpg
Embolization Coil reduced risks and cost-effectiveness, to witness a CAGR of 4.7% during 2017-2023
07 nov. 2017 08h56 HE | Energias Market Research
NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- The global embolization coil market is expected to witness a CAGR of 4.7%, and is projected to reach USD 1,003.7 Million by 2023. Factors propelling the...